Friday, May 1, 2026

Is South Korea’s AI Strategy Enough to Compete with the U.S. and China?

South Korea lags in AI investment and strategy, highlighting the need for diverse ecosystems to ensure competitiveness and innovation.

Marriage and Multiple Sclerosis: Study Finds Slower Disease Progression in Married Women

Study shows women with MS experience slower disease progression with a spouse's support, highlighting emotional and physical benefits.

Revolutionizing Antibiotic Use: Insights from Korea’s ASP Model Featured in JAMA

Korea's Antimicrobial Stewardship Program gains international recognition for optimizing antibiotic use and addressing resistance issues.

Tag: D&D Pharmatech

D&D Pharmatech signs $1.24 million obesity drug research deal with Pfizer

D&D Pharmatech partners with Pfizer for a $1.24M obesity treatment project, marking a significant revenue milestone for the company.

Is DD01 the Future of MASH Treatment? Insights from D&D Pharmatech’s JP Morgan Presentation

D&D Pharmatech's CEO highlights growth in K-bio at JPM Healthcare Conference, unveiling promising drug data and future plans for clinical trials.

Top News

- Our Sponsors Ad -

Follow us